Topic
Visceral leishmaniasis
About: Visceral leishmaniasis is a research topic. Over the lifetime, 7486 publications have been published within this topic receiving 184865 citations. The topic is also known as: Kala-Azar & viscus leishmaniasis.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The prognostic model developed in this study had satisfactory performance and might be useful in developing countries, since it is simple and inexpensive, but it is still preliminary and needs to be improved and validated using larger and more recent samples.
Abstract: Background: A possible strategy to reduce fatality rates of visceral leishmaniasis is to identify prognostic factors that can be easily assessed and used as an aid to clinical decision-making. Patients and Methods: A case-control study was developed in Teresina, Brazil, in which cases were patients who died during treatment (n = 12) and controls (n = 78) comprised a random sample of patients who were alive when treatment was finished. Results: Variables significantly associated with death were severe anemia, fever for more than 60 days, diarrhea and jaundice. The prognostic system had a sensitivity of 85.7% and a specificity of 92.5%. Conclusion: The prognostic model developed in this study had satisfactory performance and might be useful in developing countries, since it is simple and inexpensive. However, it is still preliminary and needs to be improved and validated using larger and more recent samples.
91 citations
••
TL;DR: Findings reveal a hitherto unknown IFN-β/SOD1 axis in Leishmania infection and suggest that inhibition of SOD-associated pathways could serve as strategy in the treatment of L. amazonensis as well as L. braziliensis infection, major human pathogens.
Abstract: Type I IFNs (IFN-alpha/beta) have only recently gained considerable attention as immunomodulators in nonviral infectious diseases. IFN-beta has been shown to protect, in a NO-dependent manner, against murine Old World leishmaniasis caused by Leishmania major, but data in New World leishmaniasis are lacking. We found that IFN-beta dose-dependently increases parasite burden in Leishmania amazonensis- as well as Leishmania braziliensis-infected human macrophages, independent of endogenous or exogenous NO. However, IFN-beta significantly reduced superoxide release in Leishmania-infected as well as uninfected human macrophages. This decrease in superoxide production was paralleled by a significant IFN-beta-mediated increase in superoxide dismutase 1 (SOD1) protein levels. Additionally, IFN-beta inhibition of leishmanicidal activity was mimicked by SOD1 and antagonized by either pharmacological or small interfering RNA-mediated inhibition of SOD1. Finally, pronounced SOD1 expression in situ was demonstrated in biopsies from New World cutaneous leishmaniasis patients. These findings reveal a hitherto unknown IFN-beta/SOD1 axis in Leishmania infection and suggest that inhibition of SOD-associated pathways could serve as strategy in the treatment of L. amazonensis as well as L. braziliensis infection, major human pathogens.
91 citations
••
TL;DR: A new rK39 rapid diagnostic dipstick test was compared with aspiration and a direct agglutination test for diagnosis of visceral leishmaniasis (VL) in 201 parasitologically confirmed cases and 356 clinical suspects in disease-endemic and -epidemic areas in Sudan.
Abstract: A new rK39 rapid diagnostic dipstick test (DiaMed-IT-Leish) was compared with aspiration and a direct agglutination test (DAT) for diagnosis of visceral leishmaniasis (VL) in 201 parasitologically confirmed cases, 133 endemic controls, and in 356 clinical suspects in disease-endemic and -epidemic areas in Sudan. The sensitivity of the rK39 test in parasitologically confirmed VL cases was 90%, whereas the specificity in disease-endemic controls was 99%. The sensitivity of the DAT was 98%. In clinically suspected cases, the sensitivity of the rK39 test was 81% and the specificity was 97%. When compared with the diagnostic protocol based on the DAT and aspiration used by Medecins sans Frontieres in epidemic situations, the positive predictive value was 98%, and the negative predictive value was 71%. This rK39 rapid diagnostic test is suitable for screening as well as diagnosis of VL. Further diagnostic work-up of dipstick-negative patients with clinically suspected VL is important. The ease and convenience of the dipstick test will allow decentralization and improved access to care in disease-endemic areas in Sudan.
91 citations
••
TL;DR: The emergence of leishmaniasis as an important opportunistic infection in AIDS patients portends an ominous future as the HIV pandemic sweeps into the hyperendemic areas of South America, Africa, and the Indian subcontinent.
91 citations
••
TL;DR: Clinical presentation of patients with visceral leishmaniasis with and without human immunodeficiency virus (HIV) co‐infection and factors associated with poor outcome in northwest Ethiopia are described.
Abstract: objectives To describe the clinical presentation of patients with visceral leishmaniasis (VL) with
and without human immunodeficiency virus (HIV) co-infection and factors associated with poor
outcome in northwest Ethiopia.
method Retrospective review of 241 patients with VL (92 with and 149 without HIV co-infection).
results HIV co-infection was present in 92 (38%) of the patients. Clinical presentation of VL was
indistinguishable between patients with and without HIV co-infection. Co-infected patients had a poorer
outcome i.e. either death or treatment failure (31.5% vs. 5.6%, P < 0.001). The presence of tuberculosis
or sepsis syndrome among patients with VL and HIV co-infected independently predicted death or
treatment failure [odds ratio 4.5 (95% CI 1.47–13.92, P = 0.009) and 9.1 (95% CI 2.16–37.97,
P = 0.003), respectively]. Despite having similar clinical presentation at the time of diagnosis, VL and
HIV co-infected patients had a higher mortality and treatment failure than immunocompetent patients.
conclusion The frequency of HIV co-infection among patients with VL is high in the study area, and
this co-infection was associated with death or treatment failure. The clinical management of VL in HIV
co-infected patients is a major challenge that requires new treatment approaches to improve its outcome
91 citations